Literature DB >> 16082541

Pre-formed articulating knee spacer in two-stage revision for the infected total knee arthroplasty.

R P Pitto1, C C Castelli, R Ferrari, J Munro.   

Abstract

We performed a prospective study to assess safety and effectiveness of a pre-formed articulating spacer made of gentamicin-impregnated acrylic cement in the management of infected total knee arthroplasty. Twenty-one consecutive patients with unilateral deep infection were treated by two-stage revision in two centres. Two patients were excluded, and 19 patients remained available for assessment. The mean implantation time of the spacer was 12 weeks. The rehabilitation programme between stages consisted in early range of motion exercises and partial weight bearing. Mean follow-up after removal of the spacer and insertion of the final prosthesis was 24 (range, 12-43) months. No patient had recurrence of infection at the latest follow-up. The mean Knee Society functional score during spacer management was rated 75 points and was rated 84 points at the latest follow-up. No device-related complication was observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082541      PMCID: PMC3456645          DOI: 10.1007/s00264-005-0670-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  19 in total

1.  Infected Total Knee Replacements.

Authors: 
Journal:  J Am Acad Orthop Surg       Date:  1994-01       Impact factor: 3.020

2.  The PROSTALAC functional spacer in two-stage revision for infected knee replacements. Prosthesis of antibiotic-loaded acrylic cement.

Authors:  F S Haddad; B A Masri; D Campbell; R W McGraw; C P Beauchamp; C P Duncan
Journal:  J Bone Joint Surg Br       Date:  2000-08

3.  One-stage reimplantation for infected total knee arthroplasty.

Authors:  S B Göksan; M A Freeman
Journal:  J Bone Joint Surg Br       Date:  1992-01

4.  Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections.

Authors:  H Segawa; D T Tsukayama; R F Kyle; D A Becker; R B Gustilo
Journal:  J Bone Joint Surg Am       Date:  1999-10       Impact factor: 5.284

5.  Techniques in arthroplasty. Use of an articulated PMMA spacer in the infected total knee arthroplasty.

Authors:  E J McPherson; K Lewonowski; L D Dorr
Journal:  J Arthroplasty       Date:  1995-02       Impact factor: 4.757

6.  A temporary antibiotic-loaded joint replacement system for management of complex infections involving the hip.

Authors:  C P Duncan; C Beauchamp
Journal:  Orthop Clin North Am       Date:  1993-10       Impact factor: 2.472

7.  Total knee replacement in young, active patients. Long-term follow-up and functional outcome.

Authors:  D R Diduch; J N Insall; W N Scott; G R Scuderi; D Font-Rodriguez
Journal:  J Bone Joint Surg Am       Date:  1997-04       Impact factor: 5.284

8.  Management of infected total knee arthroplasties.

Authors:  R H Walker; D J Schurman
Journal:  Clin Orthop Relat Res       Date:  1984-06       Impact factor: 4.176

9.  Long-term results of the total condylar knee arthroplasty. A 15-year survivorship study.

Authors:  C S Ranawat; W F Flynn; S Saddler; K K Hansraj; M J Maynard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

10.  Treatment of infected total knee arthroplasty.

Authors:  L A Whiteside
Journal:  Clin Orthop Relat Res       Date:  1994-02       Impact factor: 4.176

View more
  26 in total

Review 1.  Two-stage revision of septic knee prosthesis with articulating knee spacers yields better infection eradication rate than one-stage or two-stage revision with static spacers.

Authors:  C L Romanò; L Gala; N Logoluso; D Romanò; L Drago
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-01-21       Impact factor: 4.342

2.  Intraoperative molds to create an articulating spacer for the infected knee arthroplasty.

Authors:  Geoffrey S Van Thiel; Keith R Berend; Gregg R Klein; Alexander C Gordon; Adolph V Lombardi; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

3.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

4.  Utility of tibial tubercle osteotomy in the setting of periprosthetic infection after total knee arthroplasty.

Authors:  Ho-Rim Choi; Dennis Burke; Henrik Malchau; Young-Min Kwon
Journal:  Int Orthop       Date:  2012-05-12       Impact factor: 3.075

5.  Comparison of static and mobile antibiotic-impregnated cement spacers for the treatment of infected total knee arthroplasty.

Authors:  Sang-Jin Park; Eun-Kyoo Song; Jong-Keun Seon; Taek-Rim Yoon; Gi-Heon Park
Journal:  Int Orthop       Date:  2009-11-21       Impact factor: 3.075

Review 6.  Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection.

Authors:  Ryan S Charette; Christopher M Melnic
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

7.  Complications associated with 133 static, antibiotic-laden spacers after TKA.

Authors:  M Faschingbauer; R Bieger; H Reichel; C Weiner; T Kappe
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-15       Impact factor: 4.342

8.  Two-stage treatment of infected total knee arthroplasty: two to thirteen year experience using an articulating preformed spacer.

Authors:  Claudio Carlo Castelli; Valerio Gotti; Roberto Ferrari
Journal:  Int Orthop       Date:  2014-01-26       Impact factor: 3.075

9.  Treatment of knee prosthesis infections: evaluation of 15 patients over a 5-year period.

Authors:  Katrin Kösters; Reinout van Crevel; Patrick D J Sturm; B Willem Schreurs; Maarten C de Waal Malefijt; Albert van Kampen; Bart Jan Kullberg
Journal:  Int Orthop       Date:  2008-08-15       Impact factor: 3.075

Review 10.  Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach.

Authors:  Esa Jämsen; Ioannis Stogiannidis; Antti Malmivaara; Jorma Pajamäki; Timo Puolakka; Yrjö T Konttinen
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.